2025 United States Blood Testing Market Revenue Opportunities Report
Description
The 2025 United States Blood Testing Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Blood Testing Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest blood testing companies actively participating in the United States are LabCorp, Quest Diagnostics, Sonic Healthcare (Clinical Pathology Laboratories - CPL), and Bio-Reference Laboratories. LabCorp, based in North Carolina, operates over 2,000 patient service centers and processes more than 160 million tests annually, specializing in routine and specialty testing, including molecular diagnostics and genomic testing. Quest Diagnostics, headquartered in New Jersey, is a leading diagnostics provider offering a broad range of blood tests, including routine screenings and genetic testing, supported by a large network of laboratories and advanced automation.
Sonic Healthcare's Clinical Pathology Laboratories serve mainly the Southern U.S. with expertise in anatomic pathology, oncology, and molecular diagnostics, benefiting from the global network of Sonic Healthcare for enhanced reach and capabilities. Bio-Reference Laboratories, a subsidiary of Opko Health, excels in oncology, genetics, and women’s health testing, supporting precision medicine and clinical trials with proprietary assays and advanced diagnostics. These companies collectively dominate the U.S. blood testing market, driving innovation and supporting extensive clinical and hospital testing needs.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Blood Testing Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest blood testing companies actively participating in the United States are LabCorp, Quest Diagnostics, Sonic Healthcare (Clinical Pathology Laboratories - CPL), and Bio-Reference Laboratories. LabCorp, based in North Carolina, operates over 2,000 patient service centers and processes more than 160 million tests annually, specializing in routine and specialty testing, including molecular diagnostics and genomic testing. Quest Diagnostics, headquartered in New Jersey, is a leading diagnostics provider offering a broad range of blood tests, including routine screenings and genetic testing, supported by a large network of laboratories and advanced automation.
Sonic Healthcare's Clinical Pathology Laboratories serve mainly the Southern U.S. with expertise in anatomic pathology, oncology, and molecular diagnostics, benefiting from the global network of Sonic Healthcare for enhanced reach and capabilities. Bio-Reference Laboratories, a subsidiary of Opko Health, excels in oncology, genetics, and women’s health testing, supporting precision medicine and clinical trials with proprietary assays and advanced diagnostics. These companies collectively dominate the U.S. blood testing market, driving innovation and supporting extensive clinical and hospital testing needs.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
